Morepen launches first US prescription generic, eyes further filings

Business Standard reported that Morepen launched its first US prescription generic. The outlet said the launch expands the company's presence beyond API supplies into finished-dosage medicines and distribution, and that Morepen is eyeing further filings. No figures or dates were given. A generic is a medicine sold after the original maker's patent protection ends, usually at a lower price. A prescription generic is one sold in the US only against a doctor's prescription. API means active pharmaceutical ingredient, the main chemical in a medicine; Morepen has so far supplied these to other drugmakers rather than selling its own finished medicines. Finished-dosage medicines are the final tablets, capsules or other forms sold to patients. The report does not name the medicine, the partner or the size of the opportunity.

AI summary of what Business Standard reported. AI can make mistakes. Read the full story on Business Standard